This content is machine translated CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes Approximately 30–40% of patients with type 2 diabetes develop chronic kidney disease (CKD) over time. In “landmark” studies such as CREDENCE, DAPA-CKD, EMPA-KIDNEY, and several others, SGLT-2 (sodium-glucose-linked transporter 2)...…
View Post 10 min This content is machine translated Switzerland's First PTH Replacement Therapy Palopegteriparatide for Chronic Hypoparathyroidism Chronic hypoparathyroidism is one of the few endocrine disorders for which no causal hormone replacement therapy has been available for decades. Treatment focused not on the underlying hormone deficiency, but...…
View Post 4 min This content is machine translated From symptom to diagnosis Multilocular cystic renal cell carcinoma (MCRCC) MCRCC is a rare subtype of clear cell renal cell carcinoma of low malignant potential. This multilocular cystic neoplasm of the kidney presents with characteristic pathologic features and consists almost...…
View Post 5 min This content is machine translated SGLT2 inhibitors for type 2 diabetes and CKD Prediction model beats albuminuria threshold SGLT2 inhibitors also significantly reduce the risk of kidney disease progression in patients with type 2 diabetes and preserved kidney function, whereby the relative benefit is independent of albuminuria status....…
View Post 4 min This content is machine translated Incorrect type 2 diagnosis and SGLT2i led to DKA Incorrect type 2 diagnosis and SGLT2i led to DKA A patient on SGLT2 inhibitor therapy developed euglycemic diabetic ketoacidosis, which ultimately led to a diagnosis of latent autoimmune diabetes in adults (LADA). The misdiagnosis of type 2 diabetes delayed...…
View Post 5 min This content is machine translated Case study Autosomal recessive polycystic kidney disease: atypical phenotype In a 5-year-old boy with renal ultrasound findings typical of autosomal recessive polycystic kidney disease (ARPKD), numerous large liver cysts were found – atypical for this disease. Genetic analyses revealed...…
View Post 14 min This content is machine translated Adrenogenital syndrome Clinical care from birth to adulthood The care of patients with adrenogenital syndrome is challenging across the entire lifespan. Especially during adolescence and the transition to adult medicine, disease-specific knowledge, emergency competence and continuity of treatment...… CME-Test
View Post 4 min This content is machine translated From symptom to diagnosis Complicated renal cysts Renal cysts are one of the most common secondary diagnoses in abdominal imaging. Smaller cysts tend to be discovered by chance, while large cysts are diagnosed due to the associated...…
View Post 5 min This content is machine translated SGLT2 inhibitors Clear, simple language improves patient safety Sodium-glucose cotransporter 2 inhibitors (SGLT2i) were initially indicated as blood glucose-lowering drugs for type 2 diabetes. They are now widely used as first-line therapies for various indications, particularly heart failure...…
View Post 6 min This content is machine translated Recognize CKD early and avoid dialysis Screen diabetics and hypertensive patients regularly and use modern therapies High blood pressure and diabetes are the main causes of CKD – early diagnosis and treatment can reduce the risk of kidney failure and cardiorenal complications. Regular screening of these...…
View Post 6 min This content is machine translated Type 2 diabetes - glycemic control and prevention of secondary diseases Utilizing pleiotropic cardio- and nephroprotective effects of SGLT-2-i and GLP-1-RA Type 2 diabetes is currently understood to be a multisystemic disease, with the prognosis being significantly influenced by cardiac and renal pathology. An early, multimodal therapeutic approach that goes beyond...…
